STEMI and adjunctive theraphy

Session comprising selected EuroPCR 2023 Clinical Case submissions

Facilitators: G. Cayla, A. Siotia, J. Zalewski

Speakers: V. Bolis, D. Cesarini, N. Kim, H. Lam, F Spione, A. Wadkar

Summary

Delve into the world of STEMI and adjunctive therapy in this session: explore the potential impact of antiplatelet therapy on achieving an "optimal" angiographic result, gain insights into the considerations surrounding tirofiban and ticagrelor use during pregnancy and delivery, discover the role of cangrelor in the management of acute myocardial infarction and PCI, learn about the challenges encountered in treating high bleeding and high ischemic risk in STEMI patients, and much more!

Presentations available when logged in:

Could antiplatelet therapy mess up your "optimal" angiographic result
Ticagrelor and tirofiban in pregnancy and delivery: beyond labels
STEMI on table thrombolysis why
The role of cangrelor in AMI and PCI
AMI patients with high thrombotic risk and complex lesion
High bleeding and high ischaemic risk STEMI

Your free My PCR account will enable you to:

Become a PCR Companion
Access slide presentations from PCR Courses
Watch session videos and LIVE cases
Discuss cases with your peers
Submit and register for PCR Courses
Register for and view PCR Webinars
Read a selection of articles in EuroIntervention
And more…

STEMI and adjunctive theraphy

Session comprising selected EuroPCR 2023 Clinical Case submissions

Log in or create account for free